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Incidental morphological findings in colorectal adenomas
Owing to a sharp increase in the frequency of diagno-
sis of colorectal adenomas in the current era of popu-
lation screening, distinctive morphological features
are increasingly being observed. These may present
diagnostic challenges and cause clinical management
issues. Paneth cell metaplasia is a more common
occurrence, but the incidence rates of squamous
metaplasia, clear cell metaplasia, osseous metaplasia,
neuroendocrine differentiation and signet-ring cell-
like lesion are low, and they can be seen in <1% of
colorectal adenomas. Their histomorphological char-
acteristics are quite unique; ancillary studies are not
very helpful and often not needed. In this review, we
give an overview and describe the potential clinical
consequences of such incidental and special morpho-
logical findings in colorectal adenomas.
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Introduction
High numbers of colorectal adenomas are currently
being diagnosed, owing to the introduction of popula-
tion screening programmes for colorectal cancer
(CRC).1 These programmes are aimed at early detec-
tion of CRC, but also at the prevention of CRC by
removing the precursor lesions. The majority of these
precursors are conventional adenomas2: tubular,
tubulovillous and villous adenomas, with either low-
grade or high-grade dysplasia. Adenomas with dis-
tinct morphologies are increasingly being encoun-
tered, and are characterised by the presence of special
cell types, incidental findings, or metaplasias.2,3
These variants may lead to diagnostic difficulties.
For example, the presence of squamous metaplasia,4
neuroendocrine differentiation5 or signet-ring cell-like
lesions6 could give a false indication of invasive can-
cer. Although these variants are rare, awareness of
them among pathologists and clinicians is important,
especially in the current era.
On the basis of incidence rate, we give an overview
of the morphological characteristics, biological back-
ground and clinical implications of these special and
incidental findings in conventional adenomas. The
clinical implications are defined as relevant during
the diagnostic work-up (i.e. this feature might be a
diagnostic pitfall) or relevant for clinical management
(i.e. increased surveillance because of high-risk fea-
tures). If there are no clinical implications mentioned,
this means that the consequences of these special-
type polyps are similar to those of any conventional
adenoma of this size and grade of dysplasia.
Paneth cell metaplasia
S Y N O N Y M S
The synonyms are Paneth cell proliferation, promi-
nent Paneth cells, Paneth cell differentiation, Paneth
cell-containing adenoma, and Paneth cell-rich ade-
noma.
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E P I D E M I O L O G Y
The prevalence of Paneth cell metaplasia in colorectal
adenomas is high (range, 17–23%).7–10 Paneth cell
metaplasia is more frequently reported in proximal
adenomas and male patients.9,11 There is no relation-
ship with adenoma size or the age of the patient.
M O R P H O L O G Y
Paneth cells are pyramidal cells with basally situated
nuclei, and with prominent, large, eosinophilic, apical
granules that occupy most of their cytoplasm.12
Paneth cells in adenomas show a random distribution
in the adenomatous tubules, and are not confined to
the basal part9,11(Figure 1A,B).
Special stains or immunohistochemistry are not
required or recommended for detecting Paneth cells,
as they can be easily recognised by their distinctive
morphological features. However, in the literature,
various stains have been reported to facilitate
research by non-pathologists. Lysozyme can be used
as a Paneth cell marker,11,13 but lysozyme expression
in gastrointestinal tissues is less specific.11 Congo red
has been reported to enhance the visibility of Paneth
cells in adenomas,13 but this was not the case in our
study (Figure 1D). Paneth cells show uniform positiv-
ity for human defensin-5 (HD-5)11 and phospholipase
A2.14 Non-neoplastic Paneth cells show a normal
membranous pattern of b-catenin staining, whereas
Paneth cell metaplasia in adenomas shows nuclear b-
catenin staining11 (Figure 1C).
P A T H O P H Y S I O L O G Y
Paneth cells are normally found at the bases of the
crypts of Lieberk€uhn in the small intestine.12
Paneth cells can also be present in low numbers in
the proximal colon10 or throughout the colon as a
sign of chronic inflammation in patients with
inflammatory bowel disease.15,16 The granules of
Paneth cells consist of several compounds that play
a role in immunity and microbial defence. Paneth
cells are functionally similar to neutrophils, and
release their granules into the crypt lumen via exo-
cytosis when exposed to a variety of stimuli, includ-
ing acetylcholinergic agonists and bacteria or their
antigens.12
The mechanism of Paneth cell metaplasia in colo-
nic adenomas remains largely unclear. Activation of
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Figure 1. A–D, Paneth cell metaplasia (A,B, haematoxylin and eosin), with nuclear b-catenin expression (C) and absence of Congo red staining
(D).E,F, Clear cell metaplasia adjacent to dysplastic glands.G,H, Osseous metaplasia in a tubular adenoma.I,J, Signet-ring cell-like lesions, mainly
luminal, situated in dysplastic glands.K,L, Prominent goblet cells in dysplastic glands.
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the Apc–b-catenin–Tcf signalling pathway, which is
essential for intestinal homeostasis,17 but deregulated
early in colorectal carcinogenesis,18,19 may play a
role. Nuclear accumulation of b-catenin is a hallmark
of activation of this pathway,11 which can be
observed both in Paneth cell metaplasia adenomas in
mouse models and in duodenal microadenomas of
patients with familial adenomatous polyposis.11 This
activated pathway promotes commitment towards the
Paneth cell lineage via transcriptional control of
specific markers of Paneth cells, such as the defensin
genes.20 Indeed, Joo et al.11 showed that all neoplas-
tic cells with Paneth cell differentiation showed
nuclear accumulation of b-catenin and HD-5 expres-
sion. Because KRAS mutations have been identified in
areas of Paneth cell metaplasia from CRC resection
specimens,7 it has been suggested that, even without
adenomatous changes, Paneth cell metaplasia can be
considered to be preneoplastic.21 The association of
Paneth cell metaplasia with chronic inflammation
supports this hypothesis.22
C L I N I C A L I M P L I C A T I O N S
Adenomas with Paneth cell metaplasia are generally
low-grade.11,23 Moreover, in the presence of adeno-
mas with Paneth cell metaplasia, there seems to be a
lower risk of development of synchronous or meta-
chronous advanced adenomas or CRC.10 Others9
have suggested an increased risk for all synchronous
adenomas. Adenocarcinomas with Paneth cell meta-
plasia are very rare.11,23
Generally, it is believed that the presence of Paneth
cells is not associated with progression or high-risk
features in adenomas.10,11 There are no clinical
implications.
Squamous metaplasia
S Y N O N Y M S
The synonyms are squamous or squamoid morules,
and squamous differentiation.
E P I D E M I O L O G Y
Squamous metaplasia has been observed in about
0.4% of colorectal adenomas4,24,25 (5.1% in one
study26). There is no preferred location.25 The aver-
age age of the patients was 61 years (range, 39–
80 years), and the majority (76%) were men.25 There
is no information about adenoma size in relation to
squamous metaplasia.
M O R P H O L O G Y
Squamous metaplasia in colorectal adenomas consists of
nodular structures/solid nests composed of small squa-
mous cells in association with adenomatous epithelial
glands,4 and resembles the intraglandular morula of the
endometrium27 (Figure 2A,B). Usually, keratin pearls,
intercellular bridges or overt areas of keratinisation are
not identifiable.4,13,24,27,28 The metaplastic epithelium is
often located at the base of the adenomatous crypts.13,27
Nodules can also protrude into the lumen of glandular
structures or partially replace adenomatous glands with-
out forming discrete nodules.4
Squamous metaplasia in colorectal adenomas is
morphologically and qualitatively different from the
conventional squamous metaplasia that is observed
in other organs.29 Generally, colorectal squamous
metaplasia cells are relatively small, round to short-
spindled, and slightly eosinophilic, with round to oval
bland nuclei with clear intranuclear inclusions, so-
called ‘optically clear nuclei’; in contrast, squamous
metaplasia seen in other organs is characterised by
larger, polygonal, eosinophilic cells with atypical
nuclei identical to those of squamous carcinoma cells
without those inclusions.29
Pan-cytokeratin (CK) immunoreactivity is present
in areas of squamous differentiation.13,29 CK5/6 is
positive26 (Figure 2E) and p63 is negative within the
areas of squamous metaplasia (Figure 2C); there may
be focal positivity for synaptophysin and chromo-
granin.4 There is no aberrant expression of p53,28
but there is nuclear and cytoplasmic b-catenin
expression (Figure 2F) and cyclin D1 overexpres-
sion26,29 (Figure 2D).
P A T H O P H Y S I O L O G Y
There are several hypotheses regarding the origin of
the squamous components in adenomas, including
origin from heterotopic nests of squamous cells in the
colonic mucosa, differentiation of the undifferentiated
progenitor cell in the colonic epithelium, or meta-
plasia of the glandular epithelial cells into squamous
cells in response to mechanical irritation, ischaemia,
and chronic inflammation.4,13,27 Squamous meta-
plasia in colorectal polyps may even represent the
precursor of primary colorectal squamous cell carci-
noma.4,30 However, primary colorectal squamous cell
carcinoma outside the anal transitional zone is extre-
mely rare.31
In various other neoplasms, b-catenin mutation is
involved in the histogenesis of squamous metapla-
sia.28,32,33
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C L I N I C A L I M P L I C A T I O N S
The presence of squamous metaplasia does not affect
the grading of the polyp; this should be determined in
the non-metaplastic part of the polyp. Therefore, squa-
mous metaplasia does not alter clinical management.
Because squamous metaplasia mostly presents as solid
nests or pseudocribriform areas, this may be misdiag-
nosed as high-grade dysplasia when the pathologist is
not aware of this variant, or even mimic invasive car-
cinoma, especially in polyps with prolapse/torsion.4
Clear cell metaplasia
S Y N O N Y M S
The synonyms are clear cell change and clear cell
component.
E P I D E M I O L O G Y
The incidence of clear cell metaplasia in colorectal ade-
nomas is very low; in a large series of 3486 cases, it
was 0.086%.34 It has been suggested that these adeno-
mas are more often observed in the distal colon and
rectum,35,36 although this could not be confirmed in
other studies.3,37,38 The adenomas are not particularly
large, and they are found predominantly in middle-
aged men, at an average age of 54 years.3,36–38
M O R P H O L O G Y
The clear cells are predominantly columnar entero-
cytes,38 and the glands are rather compact, with
scanty intervening stroma.37 Clear cells have clear
and/or vacuolated or foamy cytoplasm. Their nuclei
are predominantly pyknotic without conspicuous
nucleoli or occasionally with one or more prominent
nucleoli, and are usually not confined to the basal
half of the cell.3,37
The clear cells typically occupy the superficial
region of the adenoma,3 but varying proportions of
the adenoma can show clear cell metaplasia, with
an abrupt transition to the remaining portion repre-
senting a typical tubular adenoma with dysplasia37
(Figure 1E,F).
A
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Figure 2. Squamous metaplasia in adenomas.A,B, Transition of dysplastic glandular structures into squamous metaplasia (haematoxylin and
eosin).C, Absence of p63 expression.D, Strong cyclin D1 expression.E, Patchy cytokeratin 5/6 expression.F, Nuclear and cytoplasmic b-cate-
nin expression.
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Clear cells have no accumulation of mucin, and
show no expression of Alcian blue or Periodic acid–
Schiff (PAS), either before or after diastase diges-
tion,37–40 in contrast to the conventional adenoma-
tous component.36,40 The clear cells show an
immunohistochemical pattern similar to that of the
adenoma component. They usually show expression
of CK20, carcinoembryonic antigen, and CDX2, con-
sistent with the finding of a colorectal origin, and are
negative for CK7, vimentin, and chromogranin.35–39
P A T H O P H Y S I O L O G Y
The mechanism responsible for clear cell metaplasia
is controversial and unclear; it could be an accumula-
tion of lipid, hydropic change, or just an artefact. His-
tochemical and ultrastructural studies (electron
microscopy) have failed to show cytoplasmic glycogen
or mucin.3,38–40 Some studies have therefore sug-
gested a degenerative nature for clear cell metaplasia,
although without any evidence.38,41
C L I N I C A L I M P L I C A T I O N S
There are no clinical implications of clear cell meta-
plasia in colorectal adenomas,3,34,39,40,42 given the
absence of clinical data.
Osseous metaplasia
S Y N O N Y M S
The synonyms are heterotopic ossification, bony
metaplasia, and heterotopic bone formation.
E P I D E M I O L O G Y
The incidence of osseous metaplasia is unknown, but
this entity is regarded as exceedingly rare. Nine cases
in total can be found in the literature.43
M O R P H O L O G Y
Osseous metaplasia refers to the formation of hetero-
topic bone by osteoblasts.44 This bone consists of
irregular islands of mineralised mature osteoid bone
rimmed by layers of scattered osteoblasts.45,46 The
foci of ossification in colorectal adenomas lack forma-
tion of bone marrow (Figure 1G,H). Fibrous stroma is
generally present between the adenomatous compo-
nent and the area of bone formation.44,47 Bony tra-
beculae can be surrounded by osteoblasts. Osteocytes
can be seen in lacunae with a few scattered
osteoclast-like multinucleated giant cells. There is no
evidence of necrosis, cartilaginous tissue or mucin
deposition in the vicinity of the bone.44 Sometimes,
calcification can be seen. No histochemical or
immunohistochemical stains are required to demon-
strate bone formation.
P A T H O P H Y S I O L O G Y
The cause of ossification is controversial. Associated
histological features comprise inflammation, pre-exist-
ing calcification, increased stromal vascularity, and
extracellular mucin deposition.48 Osseous metaplasia
has also been observed in rectal cancer, often after
neoadjuvant treatment,45 and in inflammatory and
juvenile polyps,49,50 suggesting that inflammation is
an important factor in ossification. In general, oss-
eous metaplasia occurs when osteoblasts differentiate
from fibroblasts secondary to persistent inflammation
or tissue damage, or the release of substances such as
bone morphogenetic proteins (BMPs).46,47,50–52 Local
osteogenic factors such as BMPs often stimulate the
osteoblasts to incorporate collagen fibres into new
bone.52 The phenomenon can also result from the
interaction of local physiochemical factors such as
calcium salts (calcium phosphate) with proliferating
connective tissue.45,49,53,54 Most BMPs are members
of the transforming growth factor-b superfamily and
play an integral role in the formation of new bone,
except for BMP-1, and hence BMP-2, BMP-4, BMP-5
and BMP-6 are present in the cytoplasm of tumour
cells and within the osteoblast-like cells of newly
formed bone.55 Whether these factors play a role in
adenomas is unknown.
C L I N I C A L I M P L I C A T I O N S
Osseous metaplasia in adenomas is generally a radio-
logical or histological curiosity, and is an incidental
finding with no prognostic or other clinical signifi-
cance.48,52
The spectrum of neuroendocrine
differentiation in adenomas
S Y N O N Y M S A N D R E L A T E D T E R M S
Synonyms and related terms are neuroendocrine
hyperplasia, neuroendocrine metaplasia, neuroen-
docrine cell proliferation, composite intestinal ade-
noma microcarcinoid, mixed neuroendocrine–non-
neuroendocrine neoplasm (MiNEN), and mixed ade-
noma–neuroendocrine tumour (MANET).
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E P I D E M I O L O G Y
The incidence of neuroendocrine differentiation in
adenomas is considered to be low (3.8% in one
study),26 in contrast to the high percentage of CRC
cases in which neuroendocrine cells have been identi-
fied. Depending on the definition56 and the method
used to assess the neuroendocrine cell population,
this varies between 8% and 77%.56 In an overview of
MANETs, 34 cases were described, with an equal dis-
tribution between tubular and tubulovillous adeno-
mas,57 and a remarkably high percentage of high-
grade dysplasia (15 of 34 cases). There were no clear
associations with location and variation in size.5,57
The patients were of a wide age range, i.e. 28–
82 years, and there was a nearly equal sex ratio.5,57
M O R P H O L O G Y
Neuroendocrine differentiation may be difficult to
recognise5; it can be identified at high magnification
as scattered foci next to and in between dysplastic
glands (Figure 3A,C).26 Neuroendocrine foci are con-
firmed by immunohistochemistry for synaptophysin
(Figure 3B,D) and chromogranin A.58 Neuroen-
docrine differentiation usually occupies only a minute
region in the centre of the polyp, without disturbing
the overall architecture or with clear demarcation
from the glandular component.5,26
The neuroendocrine component comprises <30% of
the adenoma by definition.59 The neuroendocrine
cells in adenomas are arranged in solid, gyriform, tra-
becular, tubuloacinar or pseudorosette patterns, with
centrally located round-to-oval nuclei, salt and pepper
chromatin, and the presence of fine eosinophilic gran-
ules on haematoxylin and eosin staining.58 Some-
times, budding of single neuroendocrine nests from
the overlying adenomatous crypts can be seen, or
even clusters of neuroendocrine nests <2 mm, limited
within the lamina propria, and distributed along the
base of the adenomatous crypts.60 They lack signifi-
cant nuclear atypia, mitotic activity, or necrosis.5
There is no increase in the Ki67 labelling index in
the cells showing neuroendocrine differentiation.5
Both nuclear immunoreactivity and cytoplasmic
immunoreactivity for b-catenin are usually present.57
P A T H O P H Y S I O L O G Y
Although gastrointestinal neuroendocrine cells are of
endodermal origin,61 neither the natural history nor
the pathogenetic mechanism for neuroendocrine dif-
ferentiation in adenomas has been fully elucidated,
partly because of under-recognition.5 Long-standing
inflammation or mechanical injury might induce
chronic mucosal injury that causes neuroendocrine
differentiation.62
Studies have proposed a role of b-catenin,57,60 with
an altered Wnt–b-catenin signalling pathway, and a
shared pathogenesis with other special types of ade-
noma.26
C L I N I C A L I M P L I C A T I O N S
To differentiate sporadic neuroendocrine differentia-
tion in adenomas from low-grade MiNEN, there is a
cut-off of 30% for the neuroendocrine compo-
nent.57,59 Low-grade MiNENs are rare, indolent
lesions that constitute approximately 5% of colorectal
MiNENs59; they usually present as polyps <30 mm in
diameter, and occasionally cause carcinoid syn-
drome.59 Local excision is generally considered to be
adequate.59
Scattered neuroendocrine cells sometimes resemble
infiltrative glands or tumour budding, but there is no
desmoplastic reaction.5 Neuroendocrine differentiation
can even resemble squamous metaplasia26 or high-
grade dysplasia.5 Awareness of the possibility of neu-
roendocrine differentiation might thus prevent over-
diagnosis. If there is doubt, immunohistochemical
confirmation is helpful.
Signet-ring cell-like lesions
S Y N O N Y M S A N D R E L A T E D T E R M S
Synonyms and related terms are benign signet-ring
cell aggregates, signet-ring cell-like changes, non-neo-
plastic signet-ring cells, pseudo-signet ring cells,
prominent goblet cells, and goblet cell-rich lesions.
E P I D E M I O L O G Y
The incidence and clinical features of signet-ring cell-
like lesions in colorectal adenomas are not known,
owing to the sparse literature. Intramucosal signet-
ring cell carcinoma is a distinct entity that is not dis-
cussed here, although it may be difficult to distin-
guish it from signet-ring cell-like lesions.
M O R P H O L O G Y
Signet-ring cells are cells with characteristic crescent-
shaped and peripherally displaced nuclei.63,64 Signet-
ring cell-like lesions consist of sloughed goblet cells,
which assume a round shape with a signet-ring
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appearance.65 Their nuclei are not enlarged, but
appear to be compressed towards the periphery of the
cell. They do not show mitoses, and have a uniform
chromatin distribution without atypia.63,65 In colorec-
tal adenomas, the formation of signet-ring cell-like
lesions can be seen as clusters or small cell groups (Fig-
ure 1I,J), which are always confined to the surface of
the mucosa or crypts of intestinal epithelium, thereby
not invading/infiltrating the lamina propria.63,65 In
some cases, the crypt epithelial cells are exclusively
goblet cells (Figure 1K,L) with marked goblet cell dis-
tension. These cells can be positive for PAS, PAS–dias-
tase, and pan-cytokeratin, similarly to true signet-ring
cells, but show a wild-type p53 staining pattern with a
low Ki67 proliferation index.63–65
P A T H O P H Y S I O L O G Y
The formation of these cells is probably caused by
stretching or torsion of the polyps, causing focal
mucosal ischaemia and sloughing of the epithelium,
resulting in the detachment of epithelial cells.63 The
sloughed epithelial cells, including the goblet cells,
accumulate in mucosal folds in which the surface
openings are obstructed. Some of the cells may
assume a round/balloon shape, and thereby a signet-
ring appearance.65
C L I N I C A L I M P L I C A T I O N S
The occurrence of signet-ring cell-like lesions in col-
orectal adenomas is a rare, non-neoplastic64 and very
misleading diagnostic pitfall.65 It needs to be differen-
tiated from colorectal or metastatic signet-ring cell
carcinoma, in order to avoid unnecessary surgical
resection.63–65
Conclusions
Increasing recognition of conventional adenomas
with special and incidental morphological features
raises questions about the impact of these features.
Whereas some forms of metaplasia are nothing more
than diagnostic curiosities, such as Paneth cell meta-
plasia and osseous metaplasia, others can be diagnos-
tically confusing.
The presence of squamous metaplasia, neuroen-
docrine differentiation and signet-ring cell-like lesions
should be recognised in order to avoid overdiagnosis.
Their aberrant growth pattern, which is sometimes
associated with epithelial misplacement, can cause
overinterpretation as high-grade dysplasia, or even
invasive carcinoma. Knowledge of the existence of
these special features and the possibly helpful stains
are provided in this article. Given the rarity of the
majority of these features, it is not feasible to provide
reliable epidemiological data. The majority of adeno-
mas are found in middle-aged male patients, as is the
case for all conventional adenomas.
When the hypotheses regarding the development of
these features in conventional adenomas are investi-
gated, the Wnt signalling pathway is often involved.
In the traditional descriptions of the adenoma–
A B
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Figure 3. Neuroendocrine differentiation in an adenoma. There are small groups of neuroendocrine cells between and beneath the dysplastic
glands (A,C, haematoxylin and eosin) with strong synaptophysin expression (B,D).
© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd, Histopathology, 78, 348–357.
354 P D Dabir et al.
carcinoma sequence, this signalling pathway is the
first to be disturbed, usually by mutations in APC.66
This raises the question of whether this pathway is
really involved in the development of special morpho-
logical features, or whether this is just a stage in the
development of any conventional adenoma. In Fig-
ure 4, we have incorporated these special features
into the adenoma–carcinoma sequence. In an early
stage of development, different targets of Wnt sig-
nalling can be affected, e.g. BMP-4, which is involved
in osseous metaplasia,55 and HD-5 for Paneth cell
metaplasia.67 If clear cell metaplasia and signet-ring
cell-like lesions are caused by degeneration, there
may not be a special molecular feature for those
types, although this has not been studied. The devel-
opment of neuroendocrine differentiation is consid-
ered to be a later event, as neuroendocrine
components of CRCs share the common mutations of
the non-neuroendocrine parts, including mutations in
APC, TP53, and KRAS.68,69 It has been suggested
that the development of neuroendocrine cells in ade-
nomas or adenocarcinomas is influenced by the phos-
phoinositide 3-kinase–Akt–mammalian target of
rapamycin pathway.70
With the increased recognition of these features
that can occur in conventional colorectal adenomas,
we will learn more about their epidemiology, and
these morphological findings may also give us
insights into carcinogenesis pathways.
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